In a whirlwind week for AI, OpenAI co-founder Ilya Sutskever’s new venture secured $1 billion for ‘safe’ superintelligence, while AI-driven drug discovery hit roadblocks in...
As artificial intelligence (AI) promises to remake drug discovery, recent clinical trial results reveal its potential and challenges. Recursion Pharmaceuticals, a self-described “clinical stage TechBio...
It was a mixed bag of growth and challenges for digital healthcare platform GoodRx during the second quarter. In reporting its second-quarter results Thursday (Aug....
As consumers weigh a wide range of factors when deciding where to make purchases, PYMNTS Intelligence finds that grocery shoppers tend to be motivated by...
As consumers grow tired of retailers’ increasing utilization of locked display cases, cable ties and electronic tags, many are switching to digital channels to eliminate...
A new study from the University of Cambridge suggests artificial intelligence (AI) could significantly accelerate the detection of antibiotic-resistant bacteria. Published in Nature Communications, the...
ENavvi has added a revamped user interface and a new, integrated ePrescribe functionality to its prescription marketplace. These updates are designed to make it easier...
Amazon said it has expanded its prescription drug program to include Medicare beneficiaries. Beginning Tuesday (June 18), more than 50 million enrollees in the government...
Despite Europe’s reputation as a tech laggard, a cadre of companies is making big bets on artificial intelligence (AI). While the region has been slow to...